Shares of Bio-Techne Corp. slipped 4.01% to $48.81 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.01% to 6,699.38 and the Dow ...

Bio-Techne develops specialized reagents and diagnostic solutions for global research and clinical markets in the life ...

ImmunityBio's stock has roughly quintupled so far in 2026 as the company continues to deliver good news for investors.

Is IBRX a good stock to buy now? We came across a bullish thesis on ImmunityBio, Inc. on r/pennystocks by Bailey-96. In this ...

KALA BIO (KALA) stock soared 70% pre-market after revealing plans to launch its first commercial AI agent in 14 days through ...

Nuvation Bio enrolled the first patient in a late-stage study of Ibtrozi. The bigger story, though, was a Wall Street analyst's initiation of coverage on the stock. Shares of Nuvation Bio (NYSE: NUVB) ...

Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...